145 related articles for article (PubMed ID: 17123788)
1. Roles for IL-1 and TNFalpha in dynamic behavioral responses of Langerhans cells to topical hapten application.
Nishibu A; Ward BR; Boes M; Takashima A
J Dermatol Sci; 2007 Jan; 45(1):23-30. PubMed ID: 17123788
[TBL] [Abstract][Full Text] [Related]
2. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli.
Nishibu A; Ward BR; Jester JV; Ploegh HL; Boes M; Takashima A
J Invest Dermatol; 2006 Apr; 126(4):787-96. PubMed ID: 16439974
[TBL] [Abstract][Full Text] [Related]
3. Local thermal injury elicits immediate dynamic behavioural responses by corneal Langerhans cells.
Ward BR; Jester JV; Nishibu A; Vishwanath M; Shalhevet D; Kumamoto T; Petroll WM; Cavanagh HD; Takashima A
Immunology; 2007 Apr; 120(4):556-72. PubMed ID: 17250587
[TBL] [Abstract][Full Text] [Related]
4. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
5. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha.
Cumberbatch M; Dearman RJ; Kimber I
Arch Dermatol Res; 1997 Apr; 289(5):277-84. PubMed ID: 9164638
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
[TBL] [Abstract][Full Text] [Related]
9. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin.
Cumberbatch M; Bhushan M; Dearman RJ; Kimber I; Griffiths CE
Clin Exp Immunol; 2003 May; 132(2):352-9. PubMed ID: 12699428
[TBL] [Abstract][Full Text] [Related]
10. IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis.
Antonopoulos C; Cumberbatch M; Mee JB; Dearman RJ; Wei XQ; Liew FY; Kimber I; Groves RW
J Leukoc Biol; 2008 Feb; 83(2):361-7. PubMed ID: 17984289
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characteristics of in vivo-activated Langerhans cells.
Aiba S; Katz SI
J Immunol; 1990 Nov; 145(9):2791-6. PubMed ID: 2170524
[TBL] [Abstract][Full Text] [Related]
12. Topical glucocorticoid augments scratching behaviour in dinitrofluorobenzene-sensitized mice by the induction of substance P.
Bae SJ; Lee JB; Takenaka M; Tanaka Y; Shimizu K; Katayama I
Exp Dermatol; 2004 Dec; 13(12):780-5. PubMed ID: 15560762
[TBL] [Abstract][Full Text] [Related]
13. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein.
Rambukkana A; Pistoor FH; Bos JD; Kapsenberg ML; Das PK
Lab Invest; 1996 Feb; 74(2):422-36. PubMed ID: 8780161
[TBL] [Abstract][Full Text] [Related]
14. IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression.
Takayama K; Yokozeki H; Ghoreishi M; Satoh T; Katayama I; Umeda T; Nishioka K
J Invest Dermatol; 1999 Oct; 113(4):541-6. PubMed ID: 10504438
[TBL] [Abstract][Full Text] [Related]
15. [Adhesion and migration of epidermal dendritic cells].
Staquet MJ
Pathol Biol (Paris); 1995 Dec; 43(10):858-62. PubMed ID: 8786890
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha and interleukin-17 differently affects Langerhans cell distribution and activation in an innovative three-dimensional model of normal human skin.
Prignano F; Arnaboldi F; Cornaghi L; Landoni F; Tripo L; Preis FW; Donetti E
Eur J Cell Biol; 2015 Feb; 94(2):71-7. PubMed ID: 25596626
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha regulates corneal Langerhans cell migration.
Dekaris I; Zhu SN; Dana MR
J Immunol; 1999 Apr; 162(7):4235-9. PubMed ID: 10201952
[TBL] [Abstract][Full Text] [Related]
18. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells.
Chang CH; Furue M; Tamaki K
Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.
Kissenpfennig A; Henri S; Dubois B; Laplace-Builhé C; Perrin P; Romani N; Tripp CH; Douillard P; Leserman L; Kaiserlian D; Saeland S; Davoust J; Malissen B
Immunity; 2005 May; 22(5):643-54. PubMed ID: 15894281
[TBL] [Abstract][Full Text] [Related]
20. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
Atarashi K; Kabashima K; Akiyama K; Tokura Y
Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
